JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 1, January 1994 TABLE OF CONTENTS
  Archives
 • Online Features
  Letters to the Editor
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

What's New in Hypertension?

Colin P. Kerr, MD, JD, MPH
The Hamburg Center Hamburg, Pa

Arch Fam Med. 1994;3(1):19.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The most important question about hypertension is: "Does the treatment of mild-to-moderate hypertension reduce cardiac mortality?" I was surprised to read in the ARCHIVES THE statement by Pearce, "The risk for MI over a 5-year period is reduced by an average of 10% with pharmacologic control of stage 1 hypertension...."' In my own recent review of this subject,2 I had arrived at a different conclusion. Wondering what I had missed, I tracked down the author's sources.

Pearce cited a 1990 article in Lancet, which reported: "In prospective observational studies, a long-term difference of 5-6 mm Hg in usual DPB [diastolic blood pressure] is associated with about 30-40% less stroke and 20-25% less coronary heart disease (CHD)."3

The article itself, however, did not support this assertion but referred to a preceding article by the same group.4 In that review of nine major, prospective, observational studies involving over 420 000 . . . [Full Text PDF of this Article]






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.

DCSIMG